Alan G Kaplan
Overview
Explore the profile of Alan G Kaplan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
202
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kaplan A
Pulm Ther
. 2024 Nov;
10(4):411-426.
PMID: 39516453
The coexistence of depression with chronic obstructive pulmonary disease (COPD) has been associated with poorer outcomes. Studies have questioned the safety of antidepressants in patients with COPD. This review shows...
2.
Bhutani M, Bourbeau J, Goodman S, Hawkins N, Kaplan A, Lin P, et al.
Int J Chron Obstruct Pulmon Dis
. 2024 Sep;
19:2051-2062.
PMID: 39318837
Background: In Canada, COPD represents a significant burden to the patient and health system, as it is often under or misdiagnosed and sub-optimally treated. Cardiovascular disease (CVD) is a common...
3.
Rozenberg D, Reid W, Camp P, Campos J, Dechman G, Davenport P, et al.
Chest
. 2024 Jun;
166(4):721-732.
PMID: 38901488
Topic Importance: Cognitive and physical limitations are common in individuals with chronic lung diseases, but their interactions with physical function and activities of daily living are not well characterized. Understanding...
4.
Bever A, Dunne J, Reynolds J, Waserman S, Kaplan A, OKeefe A, et al.
Adv Ther
. 2024 Feb;
41(4):1401-1418.
PMID: 38349560
Introduction: Biologic therapies have demonstrated benefits for individuals with severe asthma, including reduced daily symptoms and severe exacerbations. However, data describing patient perspectives on these treatments are limited. This study...
5.
Asthma Exacerbations and Glucagon-Like Peptide-1 Receptor Agonists: a Review of the Current Evidence
Kaplan A, Kim J
Pulm Ther
. 2022 Nov;
8(4):343-358.
PMID: 36417159
Asthma is a chronic inflammatory disease involving multiple mediators and cytokines. While our current treatments have shown significant therapeutic benefits, there still appear to be some patients who, despite aggressive...
6.
Pace W, Brandt E, Carter V, Chang K, Edwards C, Evans A, et al.
Ann Fam Med
. 2022 Jul;
20(4):319-327.
PMID: 35879087
Purpose: To describe demographic and clinical characteristics of chronic obstructive pulmonary disease patients managed in US primary care. Methods: This was an observational registry study using data from the Chronic...
7.
Kaplan A
Pulm Ther
. 2021 Oct;
7(2):395-408.
PMID: 34697771
Cannabis use is growing, with multiple medical 'indications' and approval for recreational use in many countries. This article will review some of the respiratory complications to cannabis use, which include...
8.
Global Quality Statements on Reliever Use in Asthma in Adults and Children Older than 5 Years of Age
Kaplan A, Correia-de-Sousa J, McIvor A
Adv Ther
. 2021 Feb;
38(3):1382-1396.
PMID: 33586006
Introduction: Widespread misuse of short-acting beta-agonists (SABAs) may contribute to asthma-related morbidity and mortality. Recognizing this, the Global Initiative for Asthma neither recommends SABA monotherapy nor regards this formulation as...
9.
Edwards C, Kaplan A, Yawn B, Kocks J, Bulathsinhala L, Carter V, et al.
Chronic Obstr Pulm Dis
. 2020 Nov;
8(1).
PMID: 33238085
Background: Chronic obstructive pulmonary disease (COPD) is commonly managed by family physicians, but little is known about specifics of management and how this may be improved. The Advancing the Patient...
10.
Kaplan A
J Am Board Fam Med
. 2020 Mar;
33(2):289-302.
PMID: 32179613
Inhaled corticosteroid (ICS)-based therapy is often used for patients with chronic obstructive pulmonary disease (COPD). However, this approach is under scrutiny because of ICS overuse in patients for whom it...